These experimental results demonstrated that butyrate impairs STAT1 nuclear translocation to reduce the binding of STAT1 with PD-L1 promoter, thereby suppressing the expression of PD-L1, which is reliant on STAT1 acetylation, in CRC cells. The gene discussed is STAT1; the disease is colorectal carcinoma.